Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice

Journal of Neuroimmunology

Volumn 96, Issue 2, 1999, Pages 207-217

  Manchester, Marianne ^a   Eto, Danelle S ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; CD46; CNS; Cytokines; Inflammation; Measles virus

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN REGION; GLIOSIS; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE MIGRATION; MEASLES; MEASLES VIRUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; TRANSGENIC MOUSE; VIRUS ENCEPHALITIS; VIRUS REPLICATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; APOPTOSIS; BIOLOGICAL MARKERS; BRAIN; CHEMOKINES; CYTOKINES; ENCEPHALITIS; GLIOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MEASLES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC;

EID: 0033519226     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00036-3     Document Type: Article

References (52)

1. Akassoglou K., Probert L., Kontogoergos G., Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158:1997;438-445.
2. Auwaerter P., Kaneshima H., McCune J.M., Wiegand G., Griffin D.E. Measles infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J. Virol. 70:1996;3734-3740.
3. Buchholz C., Schneider U., Devaux P., Gerlier D., Cattaneo R. Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J. Virol. 70:1996;3716-3723.
4. Buchholz C.J., Koller D., Devaux P., Mumenthaler C., Schneider-Schaulies J., Braun W., Gerlier D., Cattaneo R. Mapping of the primary binding site of measles virus to its receptor CD46. J. Biol. Chem. 272:1997;22072-22079.
5. Campbell I., Stalder A., Akwa Y., Pagenstecher A., Asensio V. Transgenic models to study the actions of cytokines in the central nervous system. Neuroimmunomodulation. 5:1998;126-135.
6. Cathomen T., Mrkic B., Spehner D., Drillien R., Naef R., Pavlovic J., Aguzzi A., Billeter M., Cattaneo R. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17:1998;3899-3908.
7. Devaux P., Loveland B., Christiansen D., Milland J., Gerlier D. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J. Gen. Virol. 77:1996;1477-1481.
8. Dorig R., Marcel A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305.
9. Dyken P.R., Cunningham S.C., Ward L.C. Changing character of subacute sclerosing panencephalitis in the United States. Pediatr. Neurol. 5:1989;339-341.
10. Esolen L.M., Park S.W., Hardwick J.M., Griffin D.E. Apoptosis as a cause of death in measles virus-infected cells. J. Virol. 69:1995;3955-3958.
11. Evans C.F., Horwitz M.S., Hobbs M.V., Oldstone M.B.A. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J. Exp. Med. 84:1996;2371-2384.
12. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:1997;246-257.
13. Forss-Petter S., Danielson P.E., Catsicas S., Battenberg E., Price J., Nerenberg M., Sutcliffe J.G. Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase control. Neuron. 5:1987;187-197.
14. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M., Liu Y., Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:1997;813-823.
15. Gascon G. Subacute sclerosing panencephalitis. Semin. Pediatr. Neurol. 3:1996;260-269.
16. Gogate N., Bakhiet M., Kristensson K., Norrby E., Olsson T. Gamma interferon expression and major histocompatibility complex induction during measles and vesicular stomatitis virus infections of the brain. J. Neuroimmunol. 31:1991;19-26.
17. Gogate N., Swoveland P., Yamabe T., Verma L., Woyciechowska J., Tarnowska-Dziduszko E., Dymecki J., Dhib-Jalbut S. Major histocompatibility complex class I expression on neurons in subacute sclerosing panencephalitis and experimental subacute measles encephalitis. J. Neuropathol. Exp. Neurol. 55:1996;435-443.
18. Griffin, D.E., Bellini, W.J., 1996. Measles virus. In: Fields, B.N., Knipe, D.M., Howley, P.M. (Eds.), Virology, Vol. 3. Lippincott-Raven, Philadelphia, pp. 1267-1312.
19. Hofman F.M., Hinton D.R., Baemayr J., Weil M., E M.J. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin. Immunol. Immunopathol. 58:1991;331-342.
20. Houtman J.J., Fleming J.O. Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 2:1996;361-376.
21. Hsu E.C., Dorig R.E., Sarangi F., Marcil A., Iorio C., Richardson C.D. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J. Virol. 71:1997;6144-6154.
22. Irani D.N., Griffin D.E. Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J. Immunol. 156:1996;3850-3857.
23. Iwata K., Seya T., Yanagi Y., Pesando J., Johnson P., Okabe M., Ueda S., Ariga H., Nagasawa S. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J. Biol. Chem. 270:1995;15148-15152.
24. Joly E., Mucke L., Oldstone M. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 253:1991;1283-1285.
25. Joly E., Oldstone M. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron. 8:1992;1185-1190.
26. Lawrence D.M.P., Vaughn M.M., Belman A.R., Cole J.S., Rall G.F. Immune-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and CNS disease. J. Virol. 73:1999;1795-1801.
27. Liebert U.G., Finke D. Measles virus infections in rodents. Curr. Top. Microbiol. Immunol. 191:1995;149-166.
28. Liebert U.G., Flanagan S.G., Loffler S., Baczko K., terMeulen V., Rima B.K. Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. J. Virol. 68:1994;1486-1493.
29. Liebert U.G., terMeulen V. Virological aspects of measles virus enduced encephalitis in Lewis and BN rats. J. Gen. Virol. 68:1987;1715-1722.
30. Liszewski M.K., Post T.W., Atkinson J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:1991;431-455.
31. Manchester M., Gairin J.E., Patterson J.B., Alvarez J., Liszewski M.K., Eto D.S., Atkinson J.P., Oldstone M.B.A. Measles virus recognizes its receptor, CD46, via two distinct binding sites within SCR1-2. Virology. 233:1997;174-184.
32. Manchester M., Liszewski M.K., Atkinson J.P., Oldstone M.B.A. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. USA. 91:1994;2161-2165.
33. Manchester M., Valsamakis A., Kaufman R., Liszewski M.K., Atkinson J.P., Lublin D.M., Oldstone M.B.A. Measles virus and C3 binding sites are distinct on membrane cofactor protein (MCP; CD46). Proc. Natl. Acad. Sci. USA. 92:1995;2303-2307.
34. McQuaid S., McMahon J., Herron B., Cosby S.L. Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol. Appl. Neurobiol. 23:1997;218-224.
35. Modlin J.F., Jabbour J.T., Witt J.J., Halsey N.A. Epidemiologic studies of measles, measles vaccine and subacute sclerosing panencephalitis. Pediatrics. 59:1977;505-512.
36. Monteyne P., Bureau J., Brahic M. The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 159:1997;163-176.
37. Mrkic B., Pavlovic J., Rulicke T., Volpe P., Buchholz C., Hourcade D., Atkinson J., Aguzzi A., Cattaneo R. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:1998;7420-7427.
38. Naniche D., Varior-Krishnan G., Cervino F., Wild T.F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:1993;6025-6032.
39. Niewiesk S., Brinckmann U., Bankamp B., Sirak S., Liebert U.G., terMeulen V. Susceptibility of measles virus-induced encephalitis in mice correlated with impaired antigen presentation to cytotoxic T lymphocytes. J. Virol. 67:1993;75-81.
40. Norrby E., Kristensson K. Measles virus in the brain. Brain Res. Bull. 44:1997;213-220.
41. Pantoni L., Sarti C., Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia. Artiorscler. Thromb. Vasc. Biol. 18:1998;503-513.
42. Raber J., O'Shea R., Bloom F., Campbell I. Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice. J. Neurosci. 17:1997;9473-9480.
43. Rall G., Mucke L., Oldstone M.B.A. Consequences of cytotoxic T-lymphocyte interaction with major histocompatibility complex type I expressing neurons in vivo. J. Exp. Med. 182:1995;1201-1212.
44. Rall G.F. CNS neurons: the basis and benefits of low class I major histocompatibility complex expression. Curr. Top. Microbiol. Immunol. 232:1998;115-134.
45. Rall G.F., Manchester M., Daniels L.R., Callahan E., Belman A., Oldstone M.B.A. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. USA. 94:1997;2243-2248.
46. Rima B.K., Earle J.A.P., Baczko K., terMeulen V., Liebert U.G., Carstens C., Carabana J., Caballero M., Celma M.L., Fernandez-Munoz R. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 78:1997;97-106.
47. Seya T., Turner J., Atkinson J.P. Purification and characterization of a membrane protein (gp45-70) which is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163:1986;837.
48. Smeltz R.B., Swanborg R.H. Concordance and contradiction concerning cytokines and chemokines in experimental demyelinating disease. J. Neurosci. Res. 51:1998;147-153.
49. Tyor W., Griffin D. Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice. J. Neuroimmunol. 48:1993;37-44.
50. Valsamakis A., Schneider H., Auwaerter P., Kaneshima H., Billeter M., Griffin D. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72:1998;7754-7761.
51. von Herrath M.G., Coon B., Oldstone M.B.A. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection. Virology. 229:1997;349-359.
52. von Herrath M.G., Dyrberg T., Oldstone M.B.A. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest. 98:1996;1324-1331.